» Articles » PMID: 20496533

Inflammation and Cancer: a Multifaceted Link

Overview
Date 2010 May 26
PMID 20496533
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

State Of The Art: Mounting evidence indicates a link between inflammation and cancer. However, the molecular mechanism(s) remains unclear. Indeed, although preclinical and clinical studies suggest that chronic inflammation can promote cancer development, the role(s) of inflammation in the process is likely very complex and far to be completely understood. Inflammation can promote all stages of tumor development through multiple mechanisms which include enhanced proliferation and resistance to apoptosis of initiated cells, induction of DNA mutations, promotion of angiogenesis, invasion and metastasis. On the other hand, components of tumor microenviroment, including tumor cells themselves, may promote an inflammatory state by producing inflammatory mediators. Moreover, while chronic inflammation might promote tumor formation, acute inflammation might well hamper the process and is indeed used therapeutically to inhibit tumor formation.

Conclusions: The present review briefly highlights the relationship between inflammation and tumorigenesis and discusses the possibility to develop chemoprevention and/or therapeutical approaches targeting components of the inflammatory responses.

Citing Articles

Pt(iv) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116.

Ma Z, Ding X, Zhu Z, Chen Q, Wang D, Qiao X RSC Med Chem. 2024; .

PMID: 39185449 PMC: 11342162. DOI: 10.1039/d4md00327f.


Current trends and hotspots of depressive disorders with colorectal cancer: A bibliometric and visual study.

Yan Z, Liu Y, Xu Q, Yuan Y World J Gastrointest Oncol. 2024; 16(8):3687-3704.

PMID: 39171183 PMC: 11334043. DOI: 10.4251/wjgo.v16.i8.3687.


Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.

Huang C, Liu Q, Zheng S, Liu T, Tan Y, Peng T Dig Dis Sci. 2024; 69(5):1562-1570.

PMID: 38580886 PMC: 11098888. DOI: 10.1007/s10620-024-08392-y.


Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1.

Chang J, Lo Z, Alenizi S, Kovacevic Z Cancers (Basel). 2023; 15(10).

PMID: 37345116 PMC: 10216318. DOI: 10.3390/cancers15102779.


Cathelicidin LL-37 in Health and Diseases of the Oral Cavity.

Tokajuk J, Deptula P, Piktel E, Daniluk T, Chmielewska S, Wollny T Biomedicines. 2022; 10(5).

PMID: 35625823 PMC: 9138798. DOI: 10.3390/biomedicines10051086.